- Home
- MBRX vs ICON Comparison
MBRX vs ICON Comparison
Compare MBRX & ICON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBRX
- ICON
- Stock Information
- Founded
- MBRX 2015
- ICON 2023
- Country
- MBRX United States
- ICON Greece
- Employees
- MBRX N/A
- ICON N/A
- Industry
- MBRX Biotechnology: Pharmaceutical Preparations
- ICON
- Sector
- MBRX Health Care
- ICON
- Exchange
- MBRX Nasdaq
- ICON Nasdaq
- Market Cap
- MBRX 4.4M
- ICON 3.6M
- IPO Year
- MBRX 2016
- ICON 2024
- Fundamental
- Price
- MBRX $0.81
- ICON $1.81
- Analyst Decision
- MBRX Strong Buy
- ICON Strong Buy
- Analyst Count
- MBRX 3
- ICON 1
- Target Price
- MBRX $17.33
- ICON $280.00
- AVG Volume (30 Days)
- MBRX 651.2K
- ICON 856.7K
- Earning Date
- MBRX 05-09-2025
- ICON 05-15-2025
- Dividend Yield
- MBRX N/A
- ICON 0.22%
- EPS Growth
- MBRX N/A
- ICON N/A
- EPS
- MBRX N/A
- ICON 12.11
- Revenue
- MBRX N/A
- ICON $4,810,000.00
- Revenue This Year
- MBRX N/A
- ICON $32.17
- Revenue Next Year
- MBRX N/A
- ICON $58.62
- P/E Ratio
- MBRX N/A
- ICON $0.16
- Revenue Growth
- MBRX N/A
- ICON 5.71
- 52 Week Low
- MBRX $0.40
- ICON $1.60
- 52 Week High
- MBRX $5.91
- ICON $154.00
- Technical
- Relative Strength Index (RSI)
- MBRX 33.73
- ICON N/A
- Support Level
- MBRX $0.92
- ICON N/A
- Resistance Level
- MBRX $1.04
- ICON N/A
- Average True Range (ATR)
- MBRX 0.10
- ICON 0.00
- MACD
- MBRX -0.02
- ICON 0.00
- Stochastic Oscillator
- MBRX 6.22
- ICON 0.00
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About ICON Icon Energy Corp. Common stock
Icon Energy Corp is a Growth-oriented company that operates as a holding company for the purpose of acquiring, owning, chartering and operating dry bulk vessels through its subsidiaries. The company generates its revenues by chartering the Initial Vessels to regional and international dry bulk operators, commodity traders and end users.